ANDA 78138, held by Ani Pharms. Perindopril Erbumine.
As of Nov 16, 2026, ANDA 78138 (Perindopril Erbumine), held by Ani Pharms, was first approved by FDA on Nov 10, 2009, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 10, 2009 | Original application | Approved |
| Perindopril Erbumine2MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine4MG · tablet;oral | Perindopril Erbumine | Discontinued |
| Perindopril Erbumine8MG · tablet;oral | Perindopril Erbumine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters